AMAG Pharmaceuticals (AMAG) PT Raised to $10 at SVB Leerink
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mailGet Alerts AMAG Hot Sheet
Price: $13.75 --0%
Rating Summary:
8 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 21 | New: 69
Rating Summary:
8 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 21 | New: 69
Join SI Premium – FREE
SVB Leerink analyst Ami Fadia raised the price target on AMAG Pharmaceuticals (NASDAQ: AMAG) to $10.00 (from $9.00) while maintaining a Market Perform rating.
You May Also Be Interested In
- Terna SpA (TRN:IM) (TERRF) PT Raised to EUR8.90 at Goldman Sachs
- Alibaba (9988:HK) (BABA) PT Raised to HK$195.70 at Macquarie
- Samsonite Group (1910:HK) (SMSEY) PT Raised to HK$19.80 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
